GlassScriptPhysician profile
Charles M Mixson
NPI 1053490342
$1,969.37
in general payments reported to CMS, 2019-2025
21 companies · $437 in 2025
The $437 reported for 2025 was less than what a typical Sleep Medicine (Otolaryngology) provider received nationally (typical 2025 total: $509).
See the full distribution for Sleep Medicine (Otolaryngology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $214 · 2020: $50.91 · 2021: $211 · 2022: $335 · 2023: $261 · 2024: $461 · 2025: $437.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,060 · Education: $98.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,059.57 |
| Education | $98.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $253.90 | 2022-2025 | |
| Intersect Ent, INC. | $243.00 | 2019-2022 | |
| Kaleo, INC. | $234.51 | 2019-2024 | Auvi-Q |
| Regeneron Healthcare Solutions, INC. | $203.03 | 2019-2024 | Dupixent |
| Inspire Medical Systems, INC. | $181.03 | 2023-2025 | Inspire |
| Medtronic, INC. | $176.62 | 2023-2025 | Pteye Parathyroid Detection System, Stealthstation S8 Platform |
| Optinose US, INC. | $164.66 | 2020-2025 | |
| Glaxosmithkline, LLC. | $107.08 | 2021-2024 | Nucala |
| Sanofi-Aventis U.S. LLC | $98.99 | 2024 | |
| Stryker Corporation | $92.16 | 2019-2021 | |
| Integra Lifesciences Corporation | $32.15 | 2024-2025 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Organogenesis INC. | $26.57 | 2025 | Via Matrix |
| Genzyme Corporation | $26.48 | 2022 | |
| Karl Storz Endoscopy-America | $18.51 | 2023 | Image 1 |
| Pacira Pharmaceuticals Incorporated | $17.77 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $17.44 | 2025 | Tezspire |
| Teleflex LLC | $16.95 | 2023 | Urolift |
| Covidien LP | $16.61 | 2019 | |
| Merck Sharp & Dohme LLC | $14.69 | 2023 | |
| Olympus America INC. | $14.47 | 2024 | Rhino-Laryngo Videoscope |
| Smith+Nephew, INC. | $12.75 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Mixson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.